Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma

Virology

Volumn 243, Issue 1, 1998, Pages 235-246

  Tajima, Shigeru ^a,b   Zhuang, Wen Zhong ^a   Kato, Mitsuo V ^a   Okada, Kosuke ^c   Ikawa, Yoji ^b   Aida, Yoko ^a  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c IWATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; BOVINE LEUKEMIA VIRUS; CATTLE; GENE MUTATION; GENE REPRESSION; GROWTH INHIBITION; LEUKEMOGENESIS; LYMPHOSARCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; TRANSACTIVATION; ANIMAL; CELL CULTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; VIROLOGY; VIRUS GENE;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE LEUKEMIA VIRUS; RNA VIRUSES;

ANIMALS; CATTLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; LYMPHOMA, DIFFUSE; MUTATION; PROTEIN CONFORMATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032579615     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9051     Document Type: Article

References (57)

1. Aida Y., Okada K., Amanuma H. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma. Cancer Res. 53:1993;429-437.
2. Aida Y., Kohda C., Morooka A., Nakai Y., Ogimoto K., Urao T., Asahina M. Cloning of cDNAs and the molecular evolution of a bovine MHC class IIDRA. Biochem. Biophys. Res. Commun. 204:1994;195-202.
3. Bhatia K. G., Gutierrez M. I., Huppi K., Siwarski D., Magrath I. T. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res. 52:1992;4273-4276.
4. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350:1991;429-431.
5. Burny A., Cleuter Y., Kettmann R., Mammerickx M., Marbaix G., Portetelle D., Van Den Broeke A., Willems L., Thomas R. Bovine leukemia: Facts and hypotheses derived from the study of an infectious cancer. Adv. Vet. Sci. Comp. Med. 32:1988;149-170.
6. Cesarman E., Chadburn A., Inghirami G., Gaidano G., Knowles D. M. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 80:1992;3205-3216.
7. Cheng J., Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol. 10:1990;5502-5509.
8. Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science. 265:1994;346-355.
9. Coffin J. M. Retroviridae: The viruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1767-1847.
10. Cook A., Milner J. Evidence for allosteric variants of wild-type p53, a tumor suppressor protein. Br. J. Cancer. 61:1990;548-552.
11. Crook T., Marston N. J., Sara E. A., Vousden K. H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell. 79:1994;817-827.
12. Dequiedt F., Kettmann R., Burny A., Willems L. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology. 209:1995a;676-683.
13. Dequiedt F., Kettmann R., Burny A., Willems L. Nucleotide sequence of the ovine p53 tumor-suppressor cDNA and its genomic organization. DNA Seq. 5:1995b;255-259.
14. Dequiedt F., Willems L., Burny A., Kettmann R. Nucleotide sequence of the bovine p53 tumor-suppressor cDNA. DNA Seq. 5:1995c;261-264.
15. Derse D. trans-. J. Virol. 62:1988;1115-1119.
16. Deschamp J., Kettmann R., Burny A. Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J. Virol. 40:1981;605-609.
17. Farrell P. J., Allan G. J., Shanahan F., Vousden K. H., Crook T. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 10:1991;2879-2887.
18. Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath I. T., Knowles D. M., Dalla-Favera R. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA. 88:1991;5413-5417.
19. Gannon J. V., Greaves R., Iggo R., Lane D. P. Activating mutations in p53 produce a common conformational effect: A monoclonal antibody specific for the mutant form. EMBO J. 9:1990;1591-1602.
20. Halazonetis T. D., Kandil A. N. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12:1993;5057-5064.
21. Hidaka M., Inoue J., Yoshida M., Seiki M. Posttranscriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:1988;519-523.
22. Hinds P. W., Finlay C. A., Quartin R., Baker S., Fearon E., Vogelstein B., Levine A. J. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: A comparison of the "hotspot" mutant phenotypes. Cell Growth Differ. 1:1990;571-580.
23. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 253:1991;49-53.
24. Hollstein M., Rice K., Greenblatt M. S., Soussi T., Fuchs R., Sorlie T., Hovig E., Smith-Sorensen B., Montesano R., Harris C. C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:1994;3551-3555.
25. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 350:1991;427-428.
26. Hughes S. H., Shank P. R., Spector D. H., Kung H-J., Bishop J. M., Vermus H. E., Vogt P. K., Breitman M. L. Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell. 15:1978;1397-1410.
27. Ishiguro N., Furuoka H., Matsui T., Horiuchi M., Shinagawa M., Asahina M., Okada K. p53 mutation as a potential cellular factor for tumor development in enzootic bovine leukosis. Vet. Immunol. Immunopathol. 55:1997;351-358.
28. Kato M. V., Sato H., Ishizaki K., Anzai H., Nagayoshi M., Ikawa Y. No significant changes in the expression of the fas, fasl, bcl-2 and bax genes in apoptosis of an erythroleukemic cell line by p53. Int. J. Oncol. 9:1996.
29. Kern S. E., Kinzler K. W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science. 252:1991;1708-1711.
30. Kern S. E., Pietenpol J. A., Thiagalingam S., Seymour A., Kinzler K. W., Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science. 256:1992;827-830.
31. Kettmann R., Cleuter Y., Mammerickx M., Meunier-Retival M., Bernardi G., Burny A., Chantrenne H. Genomic integration of bovine leukemia provirus: Comparison of persistent lymphocytosis with lymph node tumor form of enzootic bovine leukosis. Proc. Natl. Acad. Sci. USA. 77:1980;2577-2581.
32. Komori H., Ishiguro N., Horiguchi M., Shinagawa M., Aida Y. Predominant p53 mutations in enzootic bovine leukemic cell lines. Vet. Immunol. Immunopathol. 52:1996;53-63.
33. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 217:1970;680-685.
34. McKnight G. S. The induction of ovalbumin and conalbumin mRNA by estrogen and progesterone in chick oviduct explant cultures. Cell. 14:1978;403-413.
35. Miyasaka M., Trnka Z. Sheep as an experimental model for immunology: immunological techniques in vitro and in vivo. Lefkovits I., Parnis B. Immunological Methods. 1985;403-423 Academic Press, New York.
36. Nagata Y., Nagahisa H., Aida Y., Okutomi K., Nagasawa T., Todokoro K. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J. Biol. Chem. 270:1995;19673-19675.
37. Nishino Y., Myojin T., Kamata M., Aida Y. Human immunodeficiency virus type 1 vpr gene product prevents cell proliferation on mouse NIH3T3 cells without the G2 arrest of the cell cycle. Biochem. Biophys. Res. Commun. 232:1997;550-554.
38. Onuma M., Koyama H., Aida Y., Okada K., Ogawa Y., Kirisawa R., Kawakami Y. Establishment of B-cell lines from tumor of enzootic bovine leukosis. Leukemia Res. 10:1986;689-695.
39. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86:1989;2766-2770.
40. Pearson W. R., Lipman D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA. 85:1988;2444-2448.
41. Prives C. How loops, β sheets, and α helices helps us to understand p53. Cell. 78:1994;543-546.
42. Pietenpol J. A., Tokino T., Thiagalingam S., El-Deiry W. S., Kinzler K. W., Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA. 91:1994;1998-2002.
43. Rolley N., Butcher S., Milner J. Specific DNA binding by different classes of human p53 mutants. Oncogene. 11:1995;763-770.
44. Sagata N., Ogawa Y., Kawamura J., Onuma M., Izawa H., Ikawa Y. Molecular cloning of bovine leukemia virus DNA integrated into the bovine tumor cell genome. Gene. 26:1983;1-10.
45. BL. Proc. Natl. Acad. Sci. USA. 82:1985;7879-7883.
46. Sakashita A., Hattori T., Miller C. W., Suzushima H., Asou N., Takatsuki K., Koeffler H. P. Mutations of the p53 gene in adult T-cell leukemia. Blood. 79:1992;477-480.
47. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
48. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
49. Schreiber E., Matthias P., Muller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989.
50. Seiki M., Eddy R., Shows T. B., Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia cells. Nature. 309:1984;640-642.
51. Sodroski J. G., Rosen C. A., Haseltine W. A. trans. Science. 225:1984;381-385.
52. Stephen C. W., Lane D. P. Mutant conformation of p53: Precise epitope mapping using a filamentous phage epitope library. J. Mol. Biol. 225:1992;577-583.
53. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., Arai N. SRα promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:1988;466-472.
54. Unger T., Nau M. M., Segal S., Minna J. D. p53: A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J. 11:1992;1383-1390.
55. Wong-Staal F., Hahn B., Manzari V., Colombini S., Franchini G., Gelmann E. P., Gallo R. C. A survey of human leukaemias for sequences of a human retrovirus. Nature. 302:1983;626-628.
56. Zakut-Houri R., Bienz-Tadmor B., Givol D., Oren M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J. 4:1985;1251-1255.
57. Zambetti G. P., Olson D., Labow M., Levine A. J. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Proc. Natl. Acad. Sci. USA. 89:1992;3952-3956.